HopeStage
Back to all studies
RecruitingNCT07269873

Safety of a long-acting naltrexone implant with or without bupropion

About this titleRead the official source — NCT07269873
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 16, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
BioCorRx Pharmaceuticals Inc
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07269873
Official title
Show the full official title

A Sequential Dose Cohort Pharmacokinetic and Safety Study of Implantable Long-Acting Naltrexone Subcutaneous Pellets With or Without Bupropion Compared to Naltrexone IM Injection (Vivitrol®) in Healthy Normal Volunteers

Recruitment & locations

Currently recruiting

Miami

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is BioCorRx Pharmaceuticals Inc.

Does this study involve medication?

Yes. The study involves medication, including BICX104 naltrexone implantable pellet, Bupropion 150 mg XL and Naltrexone (depot).

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies